{"id":"https://openalex.org/W174200260","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","title":"Treatment of VHL patients with sunitinib: Clinical outcomes and translational studies.","display_name":"Treatment of VHL patients with sunitinib: Clinical outcomes and translational studies.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W174200260","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","mag":"174200260"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.3040","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085172191","display_name":"Surena F. Matin","orcid":"https://orcid.org/0000-0003-1638-1445","observed_orcids":["https://orcid.org/0000-0003-1638-1445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. F. Matin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010502061","display_name":"Ian E. McCutcheon","orcid":"https://orcid.org/0000-0002-1638-3400","observed_orcids":["https://orcid.org/0000-0002-1638-3400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. E. McCutcheon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062746651","display_name":"Dan S. Gombos","orcid":"https://orcid.org/0000-0003-2867-6320","observed_orcids":["https://orcid.org/0000-0003-2867-6320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. S. Gombos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040498568","display_name":"Steven Gerard Waguespack","orcid":"https://orcid.org/0000-0003-0280-0100","observed_orcids":["https://orcid.org/0000-0003-0280-0100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Waguespack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. M. Tannir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Wen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110288702","display_name":"Darren W. Davis","orcid":"https://orcid.org/0000-0001-6407-9430","observed_orcids":["https://orcid.org/0000-0001-6407-9430"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. W. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017694882","display_name":"Lisa A. Smith","orcid":"https://orcid.org/0000-0002-1107-6823","observed_orcids":["https://orcid.org/0000-0002-1107-6823"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. A. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012403937","display_name":"Gregory N. Fuller","orcid":"https://orcid.org/0000-0001-9447-2647","observed_orcids":["https://orcid.org/0000-0001-9447-2647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Fuller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007689146","display_name":"Eric W. Jonasch","orcid":"https://orcid.org/0000-0003-0943-2806","observed_orcids":["https://orcid.org/0000-0003-0943-2806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Jonasch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"3040","last_page":"3040"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5121999979019165,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5121999979019165,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.45509999990463257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14326","display_name":"Ear and Head Tumors","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/von-hippel-lindau-disease","display_name":"von Hippel-Lindau disease","score":0.984000027179718},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/hemangioblastoma","display_name":"hemangioblastoma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.5809999704360962},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tie2","display_name":"Tie2","score":0.6710000038146973},{"id":"https://openalex.org/keywords/fgfr3","display_name":"FGFR3","score":0.9110000133514404},{"id":"https://openalex.org/keywords/frs2","display_name":"FRS2","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tumor-endothelium","display_name":"tumor endothelium","score":0.7720000147819519},{"id":"https://openalex.org/keywords/laser-scanning-cytometry","display_name":"laser scanning cytometry","score":0.7059999704360962},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5490000247955322},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4300000071525574},{"id":"https://openalex.org/keywords/vascular-tumors","display_name":"vascular tumors","score":0.5720000267028809},{"id":"https://openalex.org/keywords/translational-biomarkers","display_name":"translational biomarkers","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8875121474266052},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.8216143846511841},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5562394857406616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5445743203163147},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5099431276321411},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46351325511932373},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.42530545592308044},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39954760670661926},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.38184112310409546},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3698921799659729},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.344188928604126},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.19328397512435913},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14015191793441772}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.3040","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.3040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W614993679","https://openalex.org/W2132423292","https://openalex.org/W2811008611","https://openalex.org/W1997507573","https://openalex.org/W2320793255","https://openalex.org/W2472578570","https://openalex.org/W2050598091","https://openalex.org/W2560033116","https://openalex.org/W2301004672","https://openalex.org/W1977494495"],"abstract_inverted_index":{"3040":[0],"Background:":[1],"Von":[2],"Hippel":[3],"Lindau":[4],"(VHL)":[5],"disease":[6],"induces":[7],"vascular":[8],"neoplasms":[9],"in":[10,23,34,153,240,262,268,278,288,308,321,333,349],"multiple":[11],"organs.":[12],"We":[13,304],"evaluate":[14],"the":[15,221,234,289,296],"safety":[16],"and":[17,27,36,63,116,129,149,156,177,191,212,220,245,250,280],"efficacy":[18,108],"of":[19,30,113,127,237,300,331],"targeted":[20],"molecular":[21],"intervention":[22],"VHL":[24,44,302],"patients":[25,350],"(pts)":[26],"examine":[28],"activation":[29,320],"various":[31],"candidate":[32],"receptors":[33],"endothelial":[35,131],"tumor":[37,154],"tissue.":[38],"Methods:":[39],"Pts":[40,72],"with":[41,186,189,193,341,351],"genetically":[42],"confirmed":[43],"were":[45,119,170,271],"enrolled.":[46],"Inclusion":[47],"criteria:":[48],"hemangioblastomas":[49],"(HBs)":[50],"at":[51],"least":[52],"5mm":[53],"dia,":[54],"renal":[55],"cell":[56],"carcinoma":[57],"(RCC)":[58],"1":[59,68],"to":[60,69,88,337],"3":[61,70,147,181],"cm":[62],"pancreatic":[64,227,314],"neuroendocrine":[65],"tumors":[66],"(NETs)":[67],"cm.":[71],"received":[73],"sunitinib":[74],"50mg/day":[75],"28":[76],"days/14":[77],"days":[78],"off":[79,200],"for":[80,107,121,202,248],"4":[81],"cycles.":[82],"Primary":[83],"endpoint":[84],"was":[85,161,242,258],"toxicity:":[86],"study":[87,201,299],"be":[89],"stopped":[90],"early":[91],"if":[92],"P":[93],"(toxicity":[94],">":[95,99],"0.3":[96],"\u03bc":[97],"g)":[98],"90%":[100],"treatment":[101,340],"terminating":[102],"toxicity.":[103,203],"Modified":[104],"RECIST":[105],"used":[106,120],"assessment.":[109],"A":[110],"separate":[111],"set":[112],"20":[114,117],"HBs":[115,312],"RCCs":[118],"laser":[122],"scanning":[123],"cytometry":[124],"(LSC)":[125],"analysis":[126,232],"total":[128],"phospho-vascular":[130],"growth":[132,138,144],"factor":[133,139,145],"receptor":[134,140,146],"(pVEGFR),":[135],"phospho-platelet":[136],"derived":[137],"(pPDGFR),":[141],"Tie-2,":[142],"fibroblast":[143],"(FGFR3),":[148],"phospho-FRS2":[150],"(pFRS2)":[151],"levels":[152,239,267],"endothelium":[155,252,270,325],"neoplastic":[157,290],"cells.":[158],"Protein":[159],"expression":[160],"analysed":[162],"using":[163],"Wilcoxon's":[164],"rank":[165],"test.":[166],"Results:":[167],"Fifteen":[168],"pts":[169,185,198],"treated.":[171],"11/15":[172],"had":[173],"RCCs,":[174],"9/15":[175],"HBs,":[176],"3/15":[178],"NETs.":[179,315],"Grade":[180],"toxicities":[182],"included":[183],"5/15":[184],"fatigue,":[187],"2/15":[188,192,197],"nausea":[190],"hand":[194],"foot":[195],"syndrome.":[196],"came":[199],"5/21":[204],"RCC":[205,251,287,309,322,338],"lesions":[206,217],"achieved":[207,218],"PR":[208],"(p=0.022),":[209],"2/21":[210],"PD,":[211,219],"14/21":[213],"SD.":[214,225,230],"2/23":[215],"HB":[216,249,269,283,324,334],"remaining":[222],"21/23":[223],"demonstrated":[224],"5/5":[226],"NETs":[228],"showed":[229],"LSC":[231],"revealed":[233],"mean":[235],"(SD)":[236],"pVEGFR":[238],"log-transformation":[241],"11.27":[243],"(0.49)":[244,273],"11.75":[246],"(0.37)":[247],"respectively":[253],"(p":[254],"=":[255],"0.003).":[256],"There":[257],"no":[259],"significant":[260],"difference":[261],"Tie2":[263],"expression,":[264],"but":[265,310],"pFRS2":[266,332],"12.5":[272],"vs.":[274,284,323],"11.91":[275],"(0.99)":[276],"(p=0.059)":[277],"RCC,":[279],"11.45":[281],"(0.26)":[282],"11.26":[285],"(0.089)":[286],"cells":[291],"(p=0.003).":[292],"Conclusions:":[293],"This":[294],"is":[295],"largest":[297],"reported":[298],"sunitinib-treated":[301],"pts.":[303],"confirm":[305],"consistent":[306],"response":[307],"not":[311],"or":[313,356,360],"Differential":[316],"dependence":[317],"on":[318],"VEGFR":[319],"may":[326,346],"explain":[327],"this":[328],"finding.":[329],"Increase":[330],"tissue":[335],"relative":[336],"suggests":[339],"FGF":[342],"pathway":[343],"blocking":[344],"agents":[345],"show":[347],"utility":[348],"HBs.":[352],"Author":[353],"Disclosure":[354],"Employment":[355],"Leadership":[357],"Position":[358],"Consultant":[359],"Advisory":[361],"Role":[362],"Stock":[363],"Ownership":[364],"Honoraria":[365],"Research":[366],"Funding":[367],"Expert":[368],"Testimony":[369],"Other":[370],"Remuneration":[371],"Pfizer":[372]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}